An R5L τ mutation in a subject with a progressive supranuclear palsy phenotype

Annals of Neurology

Volumn 52, Issue 4, 2002, Pages 511-516

  Poorkaj, Parvoneh ^a,b   Muma, Nancy A ^c   Zhukareva, Victoria ^d   Cochran, Elizabeth J ^e   Shannon, Kathleen M ^e   Hurtig, Howard ^d   Koller, William C ^f   Bird, Thomas D ^a,g   Trojanowski, John Q ^d   Lee, Virginia M Y ^d   Schellenberg, Gerard D ^a,b,g  

^a VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e RUSH UNIVERSITY MEDICAL CENTER   (United States)

^f UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPROTEIN; TAU PROTEIN;

ADULT; AGED; AMINO TERMINAL SEQUENCE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; FEMALE; GENETIC CODE; GENETIC SCREENING; HUMAN; MAJOR CLINICAL STUDY; MICROTUBULE ASSEMBLY; NUCLEOTIDE REPEAT; NUCLEOTIDE SEQUENCE; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROTEIN FUNCTION; PROTEIN SYNTHESIS; SOLUBILITY; AMINO ACID SEQUENCE; CASE REPORT; EXON; GENETICS; MIDDLE AGED; MOLECULAR GENETICS; PATHOLOGY; TAUOPATHY;

AMINO ACID SEQUENCE; EXONS; FEMALE; HUMANS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PHENOTYPE; SUPRANUCLEAR PALSY, PROGRESSIVE; TAU PROTEINS; TAUOPATHIES;

EID: 0036771837     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.10340     Document Type: Article

References (20)

1. Litvan I. Progressive supranuclear palsy revisited. Acta Neurol Scand 1998;98:468-484.
2. Steele JC, Richardson JC, Olszewski J. Progressive supranuclear palsy. Arch Neurol 1964;10:333-359.
3. Sergeant N, Wattez A, Delacourte A. Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: tau pathologies with exclusively "exon 10" isoforms. J Neurochem 1999;72:1243-1249.
4. Hutton M, Lendon CL, Rizzu P, et al. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998;393:702-705.
5. Poorkaj P, Bird TD, Wijsman E, et al. Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann Neurol 1998;43:815-825.
6. Spillantini MG, Murrell JR, Goedert M, et al. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc Nad Acad Sci USA 1998;95:7737-7741.
7. Pastor P, Pastor E, Carnero C, et al. Familial atypical progressive supranuclear palsy associated with homozygosity for the delN296 mutation in the tau gene. Ann Neurol 2001;49:263-267.
8. Reed LA, Grabowski TJ, Schmidt ML, et al. Autosomal dominant dementia with widespread neurofibrillary tangles. Ann Neurol 1997;42:564-572.
9. Stanford PM, Halliday GM, Brooks WS, et al. Progressive supranuclear palsy caused by a novel silent mutation in exon 10 of the tau gene. Brain 2000;123:880-893.
10. Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 1996;47:1-9.
11. Hong M, Zhukareva V, Vogelsberg-Ragaglia V, et al. Mutation-specific functional impairments in distinct Tau isoforms of hereditary FTDP-17. Science 1998;282:1914-1917.
12. Poorkaj P, Kas A, D'Souza I, et al. A genomic sequence analysis of the mouse and human microtubule-associated protein tau. Mamm Genome 2001;12:700-712.
13. Litvan I, Hauw JJ, Bartko JJ, et al. Validity and reliability of the preliminaty NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol 1996;55:97-105.
14. Tomonaga M. Ultrastructure of neurofibrillary tangles in progressive supranuclear palsy. Acta Neurpathol 1977;37:177-181.
15. Hayashi S, Toyoshima Y, Hasegawa M, et al. Late-onset frontotemporal dementia with a novel exon 1 (Arg5His) tau gene mutation. Ann Neurol 2002;51:525-530.
16. Goode BL, Feinstein SC. Identification of a novel microtubule binding and assembly domain in the developmentally regulated inter-repeat region of tau. J Cell Biol 1994;124:769-782.
17. Carmel G, Mager EM, Binder LI, Kuret J. The structural basis of monoclonal antibody Alz50's selectivity for Alzheimer's disease pathology. J Biol Chem 1996;271:32789-32795.
18. Chambers CB, Lee JM, Troncoso JC, et al. Overexpression of four-repeat tau mRNA isoforms in progressive supranuclear palsy but not in Alzheimer's disease. Ann Neurol 1999;46:325-332.
19. Iijima M, Tabira T, Poorkaj P, et al. A distinct familial presenile dementia with a novel missense mutation in the tau gene. Neuroreport 1999;10:497-501.
20. Goedert M, Spillantini MG, Cairns NJ, Crowter RA. Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms. Neuron 1992;8:159-168.